Latest Myeloma Podcast Episodes
Myeloma Crowd Radio: Syed Abbas Ali, Johns Hopkins
HealthTree Podcast for Multiple Myeloma - October 16, 2020 19:00 - 1 hour ★★★★★ - 13 ratingsDr. Ali is the primary investigator on a clinical trial to use a vaccine to extend remissions following successful myeloma treatment. The GVAX study is open for patients who are MRD positive but don't yet have a measurable m-protein. Dr. Ali explains how the vaccine works and why patients may wan...
HealthTree Podcast for Multiple Myeloma: Syed Abbas Ali, MD, Johns Hopkins
HealthTree Podcast for Multiple Myeloma - October 16, 2020 19:00 - 1 hour ★★★★★ - 13 ratingsDr. Ali is the primary investigator on a clinical trial to use a vaccine to extend remissions following successful myeloma treatment. The GVAX study is open for patients who are MRD positive but don't yet have a measurable m-protein. Dr. Ali explains how the vaccine works and why patients may wan...
Myeloma Crowd: Syed Abbas Ali, MD, Johns Hopkins
HealthTree Podcast for Multiple Myeloma - October 16, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsWhen should myeloma vaccines be used for patients? Dr. Syed Abbas Ali, MD of Johns Hopkins Medicine joins Myeloma Crowd Radio to share how post-treatments vaccines could be used to extend remissions after stem cell transplant or when patients are on maintenance and their myeloma is under control....
Episode 2: Anxiety with Smoldering Myeloma and MGUS
Myeloma Team Podcast - September 29, 2020 15:00 - 46 minutesThis week, Yolanda and I kept it casual. We have no interviewees, but we just missed talking. We had a conversation about whatever struck our fancy. One thing that came up was smoldering myeloma, MGUS, and the anxiety that comes with not knowing whether you’re going to progress to full blown My...
Episode 6: Anxiety with Smoldering Myeloma and MGUS
Myeloma Team Podcast - September 29, 2020 15:00 - 46 minutesThis week, Yolanda and I kept it casual. We have no interviewees, but we just missed talking. We had a conversation about whatever struck our fancy. One thing that came up was smoldering myeloma, MGUS, and the anxiety that comes with not knowing whether you’re going to progress to full blown My...
HealthTree Podcast: Krisstina Gowin, MD and Onyemaechi Okolo, MD, U of AZ
HealthTree Podcast for Multiple Myeloma - September 04, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsSince HealthTree for Multiple Myeloma started our advocacy work in myeloma, the most common question we get is “What supplements, diet or other alternative treatments will help my myeloma?” Whether it's yoga, supplements, massage therapy, Tai Chi, music therapy, IV vitamins or guidance therapy, D...
Myeloma Crowd Radio: Krisstina Gowin, MD and Onyemaechi Okolo, MD, U of AZ
HealthTree Podcast for Multiple Myeloma - September 04, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsSince the Myeloma Crowd started our advocacy work in multiple myeloma, the most common question we get is “What supplements, diet or other alternative treatments will help my myeloma?” Whether it's yoga, supplements, massage therapy, Tai Chi, music therapy, IV vitamins or guidance therapy, Dr. Kr...
Episode 5 - David Emerson of People Beat Cancer
Myeloma Team Podcast - August 28, 2020 18:00 - 43 minutes8/27/2020 Today, we had a fascinating interview with David Emerson of https://peoplebeatingcancer.org/. David led us down a tale of non-traditional medicine, Stanislaw Burzynski, antineoplaston therapy, and the flexitarian diet. Fascinating stuff that honestly just leads to more questions. W...
HealthTree Podcast for Myeloma : Keith Stewart, MB, CHB, Princess Margaret
HealthTree Podcast for Multiple Myeloma - July 28, 2020 22:30 - 1 hour ★★★★★ - 13 ratingsMyeloma specialists and myeloma patients alike want to know which treatment will work best before they are taken. Dr. Keith Stewart and colleagues from the Mayo Clinic Scottsdale have developed a new test using a "direct-to-drug" screening that helps determine how certain myeloma cells (with spec...
Myeloma Crowd Radio: Keith Stewart, MB, CHB, Princess Margaret Cancer Center
HealthTree Podcast for Multiple Myeloma - July 28, 2020 22:30 - 1 hour ★★★★★ - 13 ratingsMyeloma specialists and myeloma patients alike want to know which treatment will work best before they are taken. Dr. Keith Stewart and colleagues from the Mayo Clinic Scottsdale have developed a new test using a "direct-to-drug" screening that helps determine how certain myeloma cells (with spec...
Episode 4: About Yolanda
Myeloma Team Podcast - July 24, 2020 18:00 - 49 minutesToday, we’re keeping it light. We’re talking about my friend Yolanda, what she has going on in her world, how she’s managing and how you can reach out to her directly. Support the Show.
Episode 3 #BLM
Myeloma Team Podcast - June 16, 2020 18:00 - 58 minutesIn light of everything that’s going on in the world, we want to be real and discuss it. What’s going on? There is a global pandemic and hundreds of thousands of people are dying in the U.S. and all over the world. After a string of racially insensitive (perhaps racially motivated?) deaths at t...
HealthTree Podcast for Multiple Myeloma: Thomas Martin, MD UCSF
HealthTree Podcast for Multiple Myeloma - June 05, 2020 23:00 - 1 hour ★★★★★ - 13 ratingsIsatuxiab (Sarclisa) by Sanofi Genzyme is a new CD38-targeting monoclonal antibody that is now FDA approved to be combined with pomalidomide and dexamethasone. In the same drug class as daratumumab, isatuximab is different in its mechanism and is now being used in additional clinical trials in co...
Myeloma Crowd Radio: Thomas Martin, MD UCSF
HealthTree Podcast for Multiple Myeloma - June 05, 2020 23:00 - 1 hour ★★★★★ - 13 ratingsIsatuxiab (Sarclisa) by Sanofi Genzyme is a new CD38-targeting monoclonal antibody that is now FDA approved to be combined with pomalidomide and dexamethasone. In the same drug class as daratumumab, isatuximab is different in its mechanism and is now being used in additional clinical trials in co...
HealthTree Podcast for Myeloma: Stephen Russell, MD, PhD, Mayo Clinic and Vyriad
HealthTree Podcast for Multiple Myeloma - May 29, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsAntibody testing for COVID-19 is rapidly evolving on a daily basis. Dr. Stephen Russell is developing a new blood-based antibody test to identify neutralizing antibodies that can determine a person's immune defense against SARS-CoV-2. The project is a collaboration between Dr. Russell's company...
Myeloma Crowd Radio: Stephen Russell, MD, PhD, Mayo Clinic and Vyriad
HealthTree Podcast for Multiple Myeloma - May 29, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsAntibody testing for COVID-19 is rapidly evolving on a daily basis. Dr. Stephen Russell is developing a new blood-based antibody test to identify neutralizing antibodies that can determine a person's immune defense against SARS-CoV-2. The project is a collaboration between Dr. Russell's company...
Myeloma Crowd Radio: Ola C. Landgren, Memorial Sloan Kettering Cancer Center
HealthTree Podcast for Multiple Myeloma - April 13, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsTo date, a select number of myeloma patients have become COVID-19 positive. What have they experienced and how have they fared? Dr. Ola Landgren of Memorial Sloan Kettering Cancer Center is living in New York City, a major hot spot in the United States for COVID-19. He joins us on Myeloma Crowd R...
HealthTree Podcast for Multiple Myeloma: Ola C. Landgren, MSKCC
HealthTree Podcast for Multiple Myeloma - April 13, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsTo date, a select number of myeloma patients have become COVID-19 positive. What have they experienced and how have they fared? Dr. Ola Landgren of Memorial Sloan Kettering Cancer Center is living in New York City, a major hot spot in the United States for COVID-19. He joins us on HealthTree Podc...
Myeloma Crowd Radio: Joshua Richter, MD, Mount Sinai
HealthTree Podcast for Multiple Myeloma - March 20, 2020 18:00 - 1 hour ★★★★★ - 13 ratingsThe coronavirus (COVID-19) is causing concern and disruption for normally healthy global citizens, but there are additional issues for multiple myeloma patients who are frequent visitors to hospitals and are often immunocompromised. Learn from myeloma expert Joshua Richter, MD of Mount Sinai abou...
Myeloma Crowd Radio: Jennifer Saullo, MD, PharmD, Duke University
HealthTree Podcast for Multiple Myeloma - February 26, 2020 20:00 - 1 hour ★★★★★ - 13 ratingsInfection is a leading cause of death for multiple myeloma patients and protection against infection is key, especially during stem cell transplant. At certain points during stem cell transplant, your immune system is at an all time low until your immune system “reboots” when stem cells are given...
Myeloma Crowd Radio: Robert Z. Orlowski, MD, PhD, MD Anderson Cancer Center
HealthTree Podcast for Multiple Myeloma - January 30, 2020 17:00 - 1 hour ★★★★★ - 13 ratingsWhat innovation is coming in 2020 in myeloma research? Dr. Robert Orlowski of the the MD Anderson Cancer Center shares the insights learned from the recent American Society of Hematology meeting and highlights leading edge research expected in 2020. There is a stunning amount of development happe...
Episode 2: Dr. Gormley Part 2
Myeloma Team Podcast - December 17, 2019 20:00 - 16 minutesAt the beginning of this conversation, we talked to Dr. Gormley about the discrepancies, disparities and general distrust of our healthcare providers here in the US within african american communities. Today, we continue that discussion and ask how do we solve this? Where do grass roots begin to...
Episode 1, Dr. Nicole Gormley, Part 1
Myeloma Team Podcast - December 17, 2019 19:00 - 24 minutesThis is the Myeloma Team Podcast. Yolanda and I have come together to offer our perspective on Multiple Myeloma. She’s a fashion designer from Brooklyn and I’m a nonprofit director from Asheville, North Carolina. For all our differences, Yolanda and I have something in common - we’re both liv...
Myeloma Crowd Radio: Tanya Wildes, MD, Washington University
HealthTree Podcast for Multiple Myeloma - November 06, 2019 18:00 - 1 hour ★★★★★ - 13 ratingsMany myeloma patients are elderly, with the average age of diagnosis being 68. If individuals are fit and active, they can typically receive the "standard of care" drugs such as stem cell transplant or triplet drug combinations. But many individuals may be frail or have other health conditions th...
Myeloma Crowd Radio: Clifford Reid, PhD, Travera
HealthTree Podcast for Multiple Myeloma - October 23, 2019 17:00 - 1 hour ★★★★★ - 13 ratingsHow much does a cancer cell weigh? And why does it matter? As cancer cells die, they change their weight in a matter of hours. A new device called the Suspended Microchannel Resonator (SMR) is a new technology that can measure a small change in the weight of a single cancer cell. The SMR machine ...
Myeloma Crowd Radio: Natalie Callander, MD, University of Wisconsin
HealthTree Podcast for Multiple Myeloma - September 30, 2019 15:00 - 57 minutes ★★★★★ - 13 ratingsCellectar Biosciences is working on testing a radiosensitive therapy in blood cancers including multiple myeloma. Their product, CLR 131, targets the myeloma tumors by delivering a cytotoxic radioisotope, iodine-131 directly to the tumor cells. Phase I study results showed an overall mean surviva...
Myeloma Crowd Radio: Irene Ghobrial, MD, DFCI, PROMISE Study
HealthTree Podcast for Multiple Myeloma - September 04, 2019 17:00 - 1 hour ★★★★★ - 13 ratingsIrene Ghobrial, MD of the Dana Farber Cancer Institute and Ivan Borrello, MD of Johns Hopkins are leading the largest study on precursor myeloma conditions that will include 50,000 patients and family members. The goal of the study is to detect myeloma early and see why and how patients who have ...
Myeloma Crowd Radio: William Matsui, MD, University of Texas Dell Medical School
HealthTree Podcast for Multiple Myeloma - August 20, 2019 18:00 - 1 hour ★★★★★ - 13 ratingsWhy is a myeloma specialist so important? What does it take to create a new myeloma research center from scratch? William Matsui, MD recently left Johns Hopkins to do just that. Dr. Matsui is the Deputy Director of the new University of Texas Dell Medical School's LIVESTRONG Cancer Institutes mye...
Myeloma Crowd Radio: Paul Richardson, MD, Dana Farber Cancer Institute
HealthTree Podcast for Multiple Myeloma - July 31, 2019 14:00 - 1 hour ★★★★★ - 13 ratingsA new treatment called Selinexor was recently approved for highly relapsed multiple myeloma patients. Learn how experts like Dr. Paul Richardson of the Dana Farber Cancer Institute are using this new drug in their myeloma practice. Dr. Richardson will share how the drug works, when and how it sho...
Myeloma Crowd Radio: Alexander Lesokhin, MD, Memorial Sloan Kettering CC
HealthTree Podcast for Multiple Myeloma - May 24, 2019 15:30 - 1 hour ★★★★★ - 13 ratingsImmunotherapy is a major class of therapy that continues to expand in the myeloma clinic. Dr. Alexander Leshokin of Memorial Sloan Kettering Cancer Center explains the various types of immunotherapies: transplant, monoclonal antibodies, bi-specific antibodies, antibody drug conjugates, cellular t...
Related Myeloma Topics